Senior insider sale
Chief Executive Officer at LEGEND BIOTECH CORP — senior position signals high conviction
$1.46M
62.84K shares
What this filing means
HUANG YING plans to sell 62.84K shares of LEGEND BIOTECH CORP valued at approximately $1.46M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/29/2025ACC: 0001959173-25-007917
DirectorOfficer· Chief Executive Officer
Since Mar 2026
62.84K
Shares to sell
$1.46M
Approx. market value
61.47K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
12/19/2025
61.47KTotal acquired61.47K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/19/2025 | Restricted Stock Vesting Compensation | 61.47K | — |
| Total | 61.47K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
1.37K
Market value
$45.2K
9/24/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
61.47K
Market value
$1.41M
12/24/2025
Total
Units
62.84K
Value
$1.46M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
9/24/2025 | 1.37K | $45.2K | — | Completed |
| Planned — Approximate Date | ||||
12/24/2025 | 61.47K | $1.41M | NASDAQ | Planned |
| Total | 62.84K | $1.46M | ||